Blood lead levels in relation to cognitive function in older U.S. adults

Ahamed, 2007, Low level lead exposure and oxidative stress: current opinions, Clin Chim Acta, 383, 57, 10.1016/j.cca.2007.04.024 Basha, 2005, Lead (Pb) exposure and its effect on APP proteolysis and Abeta aggregation, FASEB J, 19, 2083, 10.1096/fj.05-4375fje Basha, 2005, The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain, J Neurosci, 25, 823, 10.1523/JNEUROSCI.4335-04.2005 Bernstein, 2007, Estimated prevalence of people with cognitive impairment: results from nationally representative community and institutional surveys, Gerontologist, 47, 350, 10.1093/geront/47.3.350 Bolin, 2006, Exposure to lead and the developmental origin of oxidative DNA damage in the aging brain, FASEB J, 20, 788, 10.1096/fj.05-5091fje Brophy, 2008, Injuries among US adults with disabilities, Epidemiology, 19, 465, 10.1097/EDE.0b013e31816932ba Centers for Disease Control and Prevention (CDC). National Health and Nutrition Examination Survey Data. Hyattsville, MD: U.S. Department of Health and Human Services CfDCaP, National Center for Health Statistics; 2009. Chadha, 1998, Targeting lead in the multimedia environment in the continental United States, J Air Waste Manage Assoc, 48, 3, 10.1080/10473289.1998.10463666 Chen, 2005, IQ and blood lead from 2 to 7 years of age: are the effects in older children the residual of high blood lead concentrations in 2-year-olds?, Environ Health Perspect, 113, 597, 10.1289/ehp.7625 Chertkow, 2008, Diagnosis and treatment of dementia: introduction. Introducing a series based on the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia, CMAJ, 178, 316, 10.1503/cmaj.070795 Chertkow, 2008, Diagnosis and treatment of dementia. 3. Mild cognitive impairment and cognitive impairment without dementia, CMAJ, 178, 1273, 10.1503/cmaj.070797 Cory-Slechta, 1990, Lead exposure during advanced age: alterations in kinetics and biochemical effects, Toxicol Appl Pharmacol, 104, 67, 10.1016/0041-008X(90)90283-Z Cory-Slechta, 2008, Lifetime consequences of combined maternal lead and stress, Basic Clin Pharmacol Toxicol, 102, 218, 10.1111/j.1742-7843.2007.00189.x Euser, 2008, Measuring cognitive function with age: the influence of selection by health and survival, Epidemiology, 19, 440, 10.1097/EDE.0b013e31816a1d31 Feldman, 2008, Diagnosis and treatment of dementia. 2. Diagnosis, CMAJ, 178, 825, 10.1503/cmaj.070798 Folsom, 2000, The generalized exponential model for sampling weight calibration for extreme values, nonresponse, and poststratification, 598 Fried, 1998, Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study, JAMA, 279, 585, 10.1001/jama.279.8.585 Gasana, 2002, Environmental lead contamination in Miami inner-city area, J Expo Anal Environ Epidemiol, 12, 265, 10.1038/sj.jea.7500227 Hernan, 2008, Cigarette smoking and dementia: potential selection bias in the elderly, Epidemiology, 19, 448, 10.1097/EDE.0b013e31816bbe14 Hornung, 2009, Age of greatest susceptibility to childhood lead exposure: a new statistical approach, Environ Health Perspect, 117, 1309, 10.1289/ehp.0800426 Hu, 1996, Determinants of bone and blood lead levels among community-exposed middle-aged to elderly men. The normative aging study, Am J Epidemiol, 144, 749, 10.1093/oxfordjournals.aje.a008999 Hu, 1998, Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms, Environ Health Perspect, 106, 1, 10.1289/ehp.981061 Idler, 1997, Self-rated health and mortality: a review of twenty-seven community studies, J Health Soc Behav, 38, 21, 10.2307/2955359 Krieg, 2009, Blood lead, serum homocysteine, and neurobehavioral test performance in the third National Health and Nutrition Examination Survey, Neurotoxicology, 30, 281, 10.1016/j.neuro.2008.12.014 Krieg, 2005, The relationship between blood lead levels and neurobehavioral test performance in NHANES III and related occupational studies, Public Health Rep, 120, 240, 10.1177/003335490512000305 Krieg, 2001, Neurobehavioral test performance in the third National Health and Nutrition Examination Survey, Neurotoxicol Teratol, 23, 569, 10.1016/S0892-0362(01)00177-5 Lanphear, 1998, Environmental exposures to lead and urban children's blood lead levels, Environ Res, 76, 120, 10.1006/enrs.1997.3801 Lanphear, 2005, Low-level environmental lead exposure and children's intellectual function: an international pooled analysis, Environ Health Perspect, 113, 894, 10.1289/ehp.7688 Leighton, 2003, The effect of lead-based paint hazard remediation on blood lead levels of lead poisoned children in New York City, Environ Res, 92, 182, 10.1016/S0013-9351(03)00036-7 Maas, 2005, Lead content and exposure from children's and adult's jewelry products, Bull Environ Contam Toxicol, 74, 437, 10.1007/s00128-005-0605-3 Meyer, 2003, Surveillance for elevated blood lead levels among children—United States, 1997–2001, MMWR Surveill Summ, 52, 1 Mielke, 1998, Soil is an important pathway of human lead exposure, Environ Health Perspect, 106, 217, 10.1289/ehp.98106s1217 Muldoon, 1996, Effects of blood lead levels on cognitive function of older women, Neuroepidemiology, 15, 62, 10.1159/000109891 Muntner, 2005, Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys, Arch Intern Med, 165, 2155, 10.1001/archinte.165.18.2155 Navas-Acien, 2007, Lead exposure and cardiovascular disease—a systematic review, Environ Health Perspect, 115, 472, 10.1289/ehp.9785 Occupational Safety and Health Administration (OSHA), 2008, 29 CFR 1910.1025 Lead, Federal Register, 73, 75585 Patterson, 2008, Diagnosis and treatment of dementia. 1. Risk assessment and primary prevention of Alzheimer disease, CMAJ, 178, 548, 10.1503/cmaj.070796 Pavlik, 2003, Relation between cognitive function and mortality in middle-aged adults: the atherosclerosis risk in communities study, Am J Epidemiol, 157, 327, 10.1093/aje/kwf209 Payton, 1998, Relations of bone and blood lead to cognitive function: the VA Normative Aging Study, Neurotoxicol Teratol, 20, 19, 10.1016/S0892-0362(97)00075-5 Perlman, 2007, Age-related differences in glucocorticoid receptor mRNA levels in the human brain, Neurobiol Aging, 28, 447, 10.1016/j.neurobiolaging.2006.01.010 Proust-Lima, 2007, Sensitivity of four psychometric tests to measure cognitive changes in brain aging-population-based studies, Am J Epidemiol, 165, 344, 10.1093/aje/kwk017 Rabinowitz, 1991, Toxicokinetics of bone lead, Environ Health Perspect, 91, 33, 10.1289/ehp.919133 Reddy, 2007, Developmental lead neurotoxicity: alterations in brain cholinergic system, Neurotoxicology, 28, 402, 10.1016/j.neuro.2006.03.018 Roberts, 2003, Using geographic information systems to assess risk for elevated blood lead levels in children, Public Health Rep, 118, 221, 10.1016/S0033-3549(04)50243-1 Sanchez-Benavides, 2009, Spanish version of the Bayer Activities of Daily Living scale in mild cognitive impairment and mild Alzheimer disease: discriminant and concurrent validity, Dement Geriatr Cogn Disord, 27, 572, 10.1159/000228259 Shih, 2006, Environmental lead exposure and cognitive function in community-dwelling older adults, Neurology, 67, 1556, 10.1212/01.wnl.0000239836.26142.c5 Shih, 2007, Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead, Environ Health Perspect, 115, 483, 10.1289/ehp.9786 Siedlecki, 2010, Do neuropsychological tests have the same meaning in Spanish speakers as they do in English speakers?, Neuropsychology, 24, 402, 10.1037/a0017515 van Wijngaarden, 2009, Bone lead levels are associated with measures of memory impairment in older adults, Neurotoxicology, 30, 572, 10.1016/j.neuro.2009.05.007 Vaziri, 2008, Mechanisms of lead-induced hypertension and cardiovascular disease, Am J Physiol Heart Circ Physiol, 295, H454, 10.1152/ajpheart.00158.2008 Vaziri, 2008, Cardiovascular effects of lead exposure, Indian J Med Res, 128, 426 Wang, 2007, Effects of Pb2+ on muscarinic modulation of glutamatergic synaptic transmission in rat hippocampal CA1 area, Neurotoxicology, 28, 499, 10.1016/j.neuro.2006.11.003 Wechsler, 1997 Weisskopf, 2007, Cumulative lead exposure and cognitive performance among elderly men, Epidemiology, 18, 59, 10.1097/01.ede.0000248237.35363.29 Weisskopf, 2004, Cumulative lead exposure and prospective change in cognition among elderly men: the VA Normative Aging Study, Am J Epidemiol, 160, 1184, 10.1093/aje/kwh333 Weuve, 2009, Cumulative exposure to lead in relation to cognitive function in older women, Environ Health Perspect, 117, 574, 10.1289/ehp.11846 White, 2007, New and evolving concepts in the neurotoxicology of lead, Toxicol Appl Pharmacol, 225, 1, 10.1016/j.taap.2007.08.001 Wright, 2003, Lead exposure biomarkers and mini-mental status exam scores in older men, Epidemiology, 14, 713, 10.1097/01.EDE.0000081988.85964.db Wu, 2008, Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD, J Neurosci, 28, 3, 10.1523/JNEUROSCI.4405-07.2008 Yaffe, 2009, Telomere length and cognitive function in community-dwelling elders: findings from the Health ABC Study, Neurobiol Aging, 10.1016/j.neurobiolaging.2007.08.003